Skip to main content

Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

IAS 2022

IAS 2022

  • Sunday, April 24, 2022
  • 9:00 AM – 9:50 AM ET
    IMIDs and Sexual function and dysfunction
  • 10:05 AM – 10:50 AM ET
    Addressing Challenges in the Management of Inflammatory Bowel Disease: The Promise of Sphingosine-1-Phosphate Receptor Modulators
  • 11:05 AM – 12:05 PM ET
    Innovation Theater (non-accredited): TREMFYA (guselkumab): TREMFYA First In Class
  • 12:20 PM – 1:05 PM ET
    Alopecia Areata: Clinical Challenges and Emerging Treatments
  • 1:20 PM – 2:20 PM ET
    Innovation Theater (non-accredited): AbbVie Innovation Theater
  • 2:35 PM – 3:20 PM ET
    Biosimilars in the Treatment of IMIDs: A Potential Path to Improved Outcomes
  • 3:35 PM – 4:20 PM ET
    Leveraging Multiomics Data to Study Autoimmune Disease in the Era of Precision Medicine
  • 4:35 PM – 5:20 PM ET
    Placebo Nocebo and the Role of the Care Settings in Clinical Response